Gelofusine affects the quality control performance of QuickVue point-of-care human chorionic gonadotropin test devices.

Objective: To characterize the influence of Gelofusine (succinylated gelatin) on the performance of point-of-care testing (POCT) for human chorionic gonadotropin (hCG) devices.

Design And Methods: Three brands of urine and urine/serum hCG POCT devices were verified.

Results: Succinylated gelatin affected the performance of the control band in the QuickVue hCG POCT devices.